CM
DMTK

Castleark Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Castleark Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-41,330
Closed -$2.1M – 364
2021
Q1 		$2.1M Buy
+41,330
New +$2.16M 0.08% 182

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Castleark Management's DMTK Position: Q2 2021 in Review

Castleark Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 41,330 shares — an estimated $2.1M sold.

Castleark Management first reported a position in DMTK in Q1 2021 and held it in 1 quarter. The position peaked at $2.1M in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

  • Castleark Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Castleark Management sold 41,330 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $2.1M.
  • Castleark Management first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Castleark Management's DermTech, Inc. Common Stock position peaked at $2.1M in Q1 2021.
  • 176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Castleark Management's 13F filing for Q2 2021, filed 17 Aug 2021.